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Abstract. 
 
By immunoaffinity purification with the 
mAb Lan3-2, we have identified two novel Ig super-
family members, Tractin and LeechCAM. LeechCAM 
is an NCAM/FasII/ApCAM homologue, whereas Trac-
tin is a cleaved protein with several unique features that 
include a PG/YG repeat domain that may be part of or 
interact with the extracellular matrix. Tractin and 
LeechCAM are widely expressed neural proteins that 
are differentially glycosylated in sets and subsets of pe-
ripheral sensory neurons that form specific fascicles in 
the central nervous system. In vivo antibody perturba-
tion of the Lan3-2 glycoepitope demonstrates that it 
can selectively regulate extension of neurites and 
filopodia. Thus, these experiments provide evidence 
that differential glycosylation can confer functional di-
versity and specificity to widely expressed neural pro-
teins.
 
N
 
eural 
 
cell adhesion molecules (CAMs)
 
1
 
 belong-
ing to the Ig superfamily are highly complex gly-
cosylated molecules with often very restricted ex-
pression patterns and multiple functional specificities
(Rathjen and Jessell, 1991; Walsh and Doherty, 1993). They
have been shown to help mediate the correct patterning of
neural connections by promoting selective outgrowth of
specific neuronal populations and by organizing similar
neurons into coherent fasciculated projections that may
serve as guides for subsequently differentiating neurons
(Goodman and Shatz, 1993; Johansen and Johansen, 1997).
Their importance for selective axon pathway formation
and maintenance is underscored by the consistent finding
that their up- or down-regulation, perturbation, or ectopic
expression in many cases leads to disrupted and disorga-
nized axonal pathways and increased navigational errors
(Keynes and Cook, 1995; Tessier-Lavigne and Goodman,
1996). In addition, increasing evidence suggests that neu-
ral CAMs also participate in activity-dependent plasticity
during development, as well as in synaptic plasticity in
adults (Rutishauser and Landmesser, 1996; Fields and Itoh,
1996). A defining feature of the molecular structure of the
neural CAMs of the Ig superfamily is the variability of
their extracellular regions, which in most cases contain
multiple tandemly arranged domains. This suggests that
they may have several different binding sites that allow
them to interact with an array of different proteins. Based
on their overall domain organization and primary struc-
ture, these proteins can be categorized into molecules
composed of (
 
a
 
) Ig-like domains only, (
 
b
 
) Ig-like domains
in conjunction with fibronectin type III (FNIII)–like do-
mains, and (
 
c
 
) Ig-like domains in combination with struc-
tural motifs other than that of FNIII (Brümmendorf and
Rathjen, 1993; Vaughn and Bjorkman, 1996). Some of the
CAMs have transmembrane and intracellular domains,
whereas others are attached to the membrane by glyco-
sylphosphatidylinositol anchors. In addition, the diversity
in the structure of neural CAMs is amplified with the ex-
istence of many splice variants and various posttransla-
tional modifications within each subgroup (Rathjen and
Jessell, 1991).
One posttranslational modification that potentially could
serve an important regulatory function for these molecules
is differential glycosylation. It has long been recognized
that the structural diversity of cell surface carbohydrates
makes them ideal candidates for mediating cell-specific
recognition processes (Roseman, 1971; Lis and Sharon,
1993; Dwek, 1995). That this is the case has been most
clearly demonstrated by the process of lymphocyte hom-
ing, which is mediated by selectins that are capable of rec-
ognizing and binding ligands expressing specific oligosac-
charide structures (Springer, 1994; Lasky, 1995). In the
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nervous system distinct carbohydrate epitopes such as that
recognized by anti-HRP antibody in insects and the HNK-
1/L2 epitope in vertebrates have been demonstrated to be
widely expressed on glycoproteins (Jessell et al., 1990). In
addition, several carbohydrate epitopes of more restricted
expression and distribution have been identified. For ex-
ample, in the vertebrate olfactory system, stage- and position-
specific carbohydrate antigens were found to be topo-
graphic markers for selective projection patterns of olfac-
tory axons (Key and Akeson, 1991; Schwarting et al.,
1992). A striking example of how the developmental regu-
lation of glycosylation can affect neural pathway forma-
tion is provided by the modulation of the polysialic acid
content of NCAM in the plexus region of the chick limb
bud where its up-regulation allows the axons to defascicu-
late into their proper pathways (Tang et al., 1992, 1994).
Furthermore, a carbohydrate moiety of a membrane-asso-
ciated glycoprotein was shown to play a role in the segre-
gation of afferent and efferent cortical axons in the white
matter (Henke-Fahle et al., 1996). Thus, specific carbohy-
drate structures on neural proteins are promising candi-
dates for assisting in patterning neural connections during
development.
A particularly advantageous system in which to study
the potential function of specific oligosaccharide modifica-
tions of neural proteins regulating pathway formation is in
the projections of sensillar neurons in leech. Using mAbs
and dye injections, the axons of sensillar neurons have been
shown to project in tightly fasciculated bundles through
the periphery into the central nervous system (CNS) where
they bifurcate and segregate into four well-defined and
stereotypically located fascicles in each of the central con-
nectives (Johansen et al., 1992; Jellies et al., 1994; Briggs
et al., 1995). At least five different mAbs (Lan3-2, Lan2-3,
Lan4-2, Laz2-369, Laz7-79) that recognize different glyco-
epitopes specific to the entire population as well as distinct
subsets of these neurons have been identified (McKay et al.,
1983; Peinado et al., 1987; Bajt et al., 1990; Johansen et al.,
1992; Zipser et al., 1994). Of these mAbs, the Lan3-2 anti-
body, which labels all sensillar neurons, has been the most
extensively studied since it has been demonstrated that
Fab fragments of Lan3-2 antibody can perturb normal fas-
cicle formation in vitro (Zipser et al., 1989; Song and Zip-
ser, 1995
 
a
 
), directly implicating a functional role for this
epitope in pathway formation. The other four mAbs label
subsets of the Lan3-2–positive sensillar neurons that selec-
tively express different glycoepitopes that appear to be
correlated with their choices of particular pathways. For
example, early in embryogenesis the Lan4-2 antibody rec-
ognizes only a few peripheral neurons, the projections of
which are confined to extending along only one of the four
Lan3-2–positive fascicles (Johansen et al., 1992). Further-
more, perturbation studies with the mAbs Laz2-369 and
Laz7-79 show that only the subset of neurites expressing
the corresponding glycoepitopes is functionally affected
by the incubation (Song and Zipser, 1995
 
b
 
). Thus, there is
compelling evidence that a hierarchy of distinct carbohy-
drate structures expressed by specific neurons is involved
in regulating neuronal pathway formation in this system.
However, an impediment to the further analysis of these
aspects has been a lack of knowledge of the molecules car-
rying the glycosylated epitopes.
In this study we have used immunoaffinity purification
techniques with the Lan3-2 antibody to identify the mole-
cules carrying the Lan3-2 and Lan4-2 glycoepitopes. We
show that both epitopes are expressed on two novel Ig su-
perfamily members, which we have named Tractin and
LeechCAM. Tractin has a highly unusual structure: it con-
tains six Ig-like domains, four FNIII-like domains, an
acidic domain, twelve repeats of a novel proline- and gly-
cine-rich motif, a transmembrane domain, and an intracel-
lular domain with an ankyrin binding motif. Tractin pos-
sesses a potential cleavage site that in conjunction with
other evidence suggests that the NH
 
2
 
-terminal half of the
molecule is secreted. LeechCAM has five Ig-like domains,
two FNIII-like domains, and a transmembrane domain
and may be a leech homologue of NCAM (Cunningham et
al., 1987), FasII (Harrelson and Goodman, 1988), and Ap-
CAM (Mayford et al., 1992). Tractin and LeechCAM are
expressed by both peripheral and central neurons but are
differentially glycosylated with the Lan3-2 and Lan4-2 epi-
topes only in the peripheral sensory neurons and their ax-
onal projections. In vivo functional studies injecting puri-
fied Lan3-2 antibody into the germinal plate show that
normal neurite extension and fascicle formation of the
sensillar sensory neurons are impaired by the antibody,
while the development and projections of central neurons
expressing Tractin and LeechCAM but not carrying the
Lan3-2 glycoepitope are indistinguishable from controls.
These findings suggest that differential glycosylation of
widely expressed neural CAMs can functionally regulate
neuronal outgrowth and fascicle formation of distinct neu-
ronal subpopulations.
 
Materials and Methods
 
Experimental Preparations
 
For the present experiments we used the two hirudinid leech species
 
Hirudo medicinalis
 
 and 
 
Haemopis marmorata.
 
 The leeches were either
captured in the wild or purchased from commercial sources. Dissections of
nervous tissue and embryos were performed in leech saline solutions with
the following composition (mM): 110 NaCl, 4 KCl, 2 CaCl
 
2
 
, 10 glucose, 10
Hepes, pH 7.4. In some cases, 8% ethanol was added and the saline solu-
tion was cooled to 4
 
8
 
C to inhibit muscle contractions. Breeding, mainte-
nance, and staging of 
 
Hirudo medicinalis
 
 embryos at 22
 
8
 
–25
 
8
 
C were as
previously described (Fernández and Stent, 1982; Jellies et al., 1987), ex-
cept that embryos were maintained in embryo water that was made as
sterile-filtered solutions of 0.0005% commercial sea salt (Instant Ocean).
Embryonic day 10 (E10) was characterized by the first sign of a tail
sucker, while E30 is the termination of embryogenesis. There are 
 
z
 
10–20
embryos in each cocoon and these sibling embryos develop synchro-
nously.
 
Protein Purification and Microsequencing
 
Purification of the Lan3-2 glycoproteins was achieved by constructing an
immunoaffinity column of protein G–Sepharose (Pharmacia Fine Chemi-
cals, Piscataway, NJ) to which purified mAb Lan3-2 had been covalently
coupled by dimethyl pimelimidate dihydrochloride (Pierce Chemical Co.,
Rockford, IL) according to the method of Schneider et al. (1982) at a ratio
of 2.5 mg mAb per ml of matrix. The mAb Lan3-2 was purified from hy-
bridoma culture supernatant grown in DME (GIBCO BRL; Gaithers-
burg, MD) containing the serum-free supplement Nutridoma (Boehringer
Mannheim Biochemicals, Indianapolis, IN) by binding to a protein
G–Sepharose matrix. Purified Lan3-2 antibody eluted from the protein
G–Sepharose matrix was 
 
.
 
99% pure as judged by SDS-PAGE and silver
staining of the gel. A nonspecific purified mouse IgG (Sigma Chemical
Co., St. Louis, MO) protein G–Sepharose column was constructed simi-
larly. All subsequent steps were performed at 4
 
8
 
C unless stated otherwise. 
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200 
 
Haemopis
 
 leech nerve cords were homogenized in 2 ml of extraction
buffer (20 mM Tris-HCl, 200 mM NaCl, 1 mM MgCl
 
2
 
, 1 mM CaCl
 
2
 
, 0.2%
NP-40, 0.2% Triton X-100, pH 7.4) containing protease inhibitors. The
homogenate was incubated on ice for 1 h and cleared by centrifugation at
13,000 
 
g
 
 for 20 min and at 100,000 
 
g
 
 for 45 min. The cleared homogenate
was then incubated with 1 ml of the nonspecific mouse IgG-bound protein
G–Sepharose for 4–8 h and centrifugated for 30 s at 2,000 
 
g.
 
 The resulting
supernatant was incubated with 1 ml of mAb Lan3-2–bound protein G–Seph-
arose overnight. This slurry was then applied to a Bio-Rad column (Bio Rad
Laboratories, Hercules, CA), which was sequentially washed with 5–10 ml
of each of the following buffers containing protease inhibitors: (
 
a
 
) extrac-
tion buffer; (
 
b
 
) 20 mM Tris-HCl, 200 mM NaCl, 0.2% NP-40, 0.2% Triton
X-100, pH 8.2; (
 
c
 
) 50 mM Tris-HCl, 1 M NaCl, 0.5% NP-40, pH 8.2; (
 
d
 
) 50
mM Tris-HCl, 150 mM NaCl, pH 8.2; and (
 
e
 
) 20 mM Tris-HCl, 150 mM
NaCl, 0.5% sodium deoxycholic acid, pH 8.2. After these washes the col-
umn was disconnected from the chromatography system and rinsed with a
buffer containing 20 mM Tris-HCl, 150 mM NaCl, 1 mM EDTA, 1 mM
EGTA, 0.1% NP-40, pH 8.2, and the bound Lan3-2 antigen was eluted
with 1 ml of 0.5 M methyl 
 
a
 
-
 
d
 
-mannopyranoside in the same buffer after
incubation for 45 min. The elution process was repeated once and the
eluted solutions were combined before dialysis against a buffer containing
10 mM NH
 
4
 
CO
 
3
 
, 0.02% SDS, pH 7.8. The resulting eluate was concentrated
with a Centricon-50 spin column (Amicon Corp., Beverly, MA) at 5,000 
 
g.
 
For protein microsequencing the Lan3-2 immunoaffinity-purified pro-
teins were separated by 7.5% SDS-PAGE, followed by electroblotting
onto Immobilon P
 
SQ
 
 membrane (Millipore Corp., Bedford, MA), and the
transferred proteins were stained by 0.1% amido black in 10% acetic acid.
The amido black–labeled electroblot was put in a sealed plastic bag and
sent to the Wistar Institute Protein Microsequencing Facility (3601 Spruce
Street, Philadelphia, PA 19104). At the Wistar Institute the broad 130-kD
band was cut out and in situ digested with trypsin, the cleaved peptides
were separated by microbore HPLC, and the fractions were screened by
mass spectrometry. Seven fractions were selected for gas phase microse-
quencing of which one fraction yielded two peptide sequences for a total
of eight.
 
Antibodies and Antibody Production
to Synthetic Peptides
 
Three previously reported mAbs, Lan3-2 (IgG
 
1
 
) and Lan4-2 (IgG
 
1
 
) (Zip-
ser and McKay, 1981; McKay et al., 1983), as well as an antibody to acety-
lated tubulin (IgG
 
2B
 
) (Sigma Chemical Co.), were used in these studies. In
addition, new antibodies were made to synthetic peptides based on the
microsequence obtained from the purified Lan3-2 antigen. Three peptides
were synthesized: pep2, 
 
C
 
YNLDYEGNFHFANVMEEDHR-NH
 
2
 
; pep3,
MEEVEIP
 
C
 
EA
 
C
 
-NH
 
2
 
 (both by QCB Inc., Hopkinton, MA), and pep6,
 
S
 
HHYNLEWEKPETGGSPIR
 
C
 
-NH
 
2
 
 (by Chiron Mimotopes, Emery-
ville, CA). A cysteine (
 
bold
 
) was added to the end of each peptide for cou-
pling purposes and two residues (
 
italics
 
) were modified by acetylation.
The peptides were covalently coupled to keyhole limpet hemocyanin (Pierce
Chemical Co.) carrier protein with sulfosuccinimidyl 4-(
 
N
 
-maleimido-
methyl) cyclohexane-1-carboxylate (Pierce Chemical Co.) as per manu-
facturer’s instructions. Two rabbits were injected with 200–400 
 
m
 
g of each
of the coupled peptides in Freund’s complete adjuvant (GIBCO BRL),
and then boosted at 21-d intervals using Freund’s incomplete adjuvant as
described in Harlow and Lane (1988). After the second boost, serum sam-
ples were collected 7 and 10 d after injection. The sera were analyzed for
specificity by comparing the staining obtained with the antisera and the
preimmune sera on nitrocellulose filters spotted with the synthetic pep-
tides coupled to BSA. Specific antisera were obtained for all three pep-
tides and were titrated from undiluted to a 1:5,000 dilution in Blotto
(0.5% Carnation nonfat dry milk in TBS). In addition to the rabbit anti-
sera, the mAb 4G5 was generated against pep2 by injecting Balb C mice
with 50 
 
m
 
g of the keyhole limpet hemocyanin–coupled peptide at 21-d in-
tervals. After the third boost, spleen cells of the mice were fused with Sp2
myeloma cells and a monospecific hybridoma line was established using
standard procedures (Harlow and Lane, 1988). 4G5 ascites were obtained
by injecting four mice intraperitoneally with antibody-producing hybrid-
oma cells. The 4G5 mAb is of the IgG
 
1
 
 subtype. All procedures for mAb
production were performed by the Iowa State University Hybridoma Fa-
cility.
 
Molecular Cloning and Sequence Analysis
 
Rabbit antisera to pep2 and pep6 sequence at a dilution of 1:4,000 were
used to screen a random primed 
 
Hirudo
 
 CNS-enriched cDNA 
 
l
 
-ZAP II
expression library essentially according to the procedures of Sambrook et al.
(1989). A total of 10
 
6
 
 plaques was screened at a density of 30,000 plaque-
forming units per 150-mm plate. Positive clones were in vivo excised to
generate pBluescript phagemids according to the method provided by the
manufacturer (Stratagene, La Jolla, CA). One partial Tractin cDNA was
identified by the pep2 antiserum and two partial LeechCAM cDNA
clones were identified by the pep6 antiserum in these screens. To obtain
the full sequence of the cDNAs for Tractin and LeechCAM, the same
cDNA library was rescreened using 
 
32
 
P-labeled fragments of the originally
identified clones. The fragments were radiolabeled using random priming
according to the manufacturer’s procedure (Prime-a-Gene kit; Promega,
Madison, WI), and the library was screened using standard procedures
(Sambrook et al., 1989).
DNA sequencing was performed using a DNA Sequencer 377A (Ap-
plied Biosystems, Foster City, CA) at the Iowa State University Nucleic
Acid Sequencing Facility using commercially available universal and re-
verse sequencing primers (Stratagene) or specific primers synthesized at
the Iowa State University Nucleic Acid Synthesis Facility based on known
Tractin and/or LeechCAM sequences. The nucleotide and predicted
amino acid sequences were analyzed using the Genetics Computer Group
(GCG package, version 8; Madison, WI) suite of programs (Devereux et al.,
1984). The Tractin and LeechCAM sequences were compared with known
and predicted proteins in the SwissProt and GenBank databases using the
FASTA and TFASTA programs within the GCG package. In addition, a
BLAST search was performed using the National Center for Biotechnol-
ogy Information BLAST e-mail server (Altschul et al., 1990) comparing
the Tractin and LeechCAM sequences with SwissProt, PIR, and GenPept
databases.
 
Northern Blot Analysis
 
Total RNA was prepared from whole leech according to the method of
Chomczynski and Sacchi (1987) with minor modifications. 5–6 g of adult
 
Hirudo
 
 leeches frozen with liquid nitrogen was ground in a coffee grinder
with dry ice to a fine powder. The leech powder was mixed thoroughly
with 60 ml of denaturing solution (4 M guanidinium thiocyanate, 25 mM
sodium citrate, 0.5% sodium lauryl sarcosinate, 0.1 M 
 
b
 
-mercaptoethanol,
pH 7.0), to which the following solutions were sequentially added with
thorough mixing: (
 
a
 
) 6 ml of 2 M sodium acetate, pH 4; (
 
b
 
) 60 ml of phe-
nol (Tris-HCl saturated); and (
 
c
 
) 12 ml of chloroform-isoamyl alcohol
mixture (49:1). The suspension was vigorously shaken and centrifuged at
10,000 
 
g
 
 for 20 min at 4
 
8
 
C. The aqueous phase was extracted and precipi-
tated with 1 vol (
 
z
 
60 ml) of isopropanol at 
 
2
 
20
 
8
 
C for at least 1 h before
centrifugation at 10,000 
 
g
 
 for 20 min at 4
 
8
 
C. The resulting RNA pellet was
dissolved in 6 ml of denaturing solution, and the above acid, guanidinium
thiocyanate-phenol-chloroform extraction and isopropanol precipitation
were repeated. The RNA pellet was washed with 70% ethanol, vacuum
dried, and dissolved in diethyl pyrocarbonate–treated H
 
2
 
O. PolyA
 
1
 
 mRNA
was isolated using an oligo-dT column matrix (New England Biolabs,
Beverly, MA) based on standard protocols (Sambrook et al., 1989). 20 
 
m
 
g
of polyA
 
1
 
 mRNA was fractionated on 1.2% agarose formaldehyde gels,
transferred to nitrocellulose, and hybridized to [
 
32
 
P]dCTP-labeled Tractin
or leechCAM probes according to standard methods (Ausubel et al.,
1987). High stringency hybridization and washing conditions were used
(Ausubel et al., 1987), and the filters were exposed to X-OMAT XAR film
(Eastman Kodak Co., Rochester, NY) at 
 
2
 
80
 
8
 
C with an intensifying screen.
 
Biochemical Analysis
 
SDS-PAGE, Western Blotting, and Two-dimensional Gel Electrophoresis.
 
SDS-PAGE was performed according to standard procedures (Laemmli,
1970). Electroblot transfer was performed as in Towbin et al. (1979) with
0.5
 
3
 
 buffer containing 5% methanol. For these experiments we used the
Bio-Rad Mini PROTEAN II system, electroblotting to 0.2-
 
m
 
m nitrocellu-
lose and using either anti–mouse or anti–rabbit HRP-conjugated second-
ary antibody (Bio Rad Laboratories) (1:3,000) for visualization of primary
antibody diluted 1:2,000 in Blotto for immunoblot analysis. The signal was
developed with DAB (0.1 mg/ml) and H
 
2
 
O
 
2
 
 (0.03%) and enhanced with
0.008% NiCl
 
2
 
. In some experiments, gels were fixed and silver stained us-
ing the Bio-Rad Silver Stain Kit as per the manufacturer’s instructions.
The Western blots were digitized using the NIH-Image software, a high
resolution cooled CCD camera (Paultek, Grass Valley, CA), and a Pixel-
Buffer framegrabber (Perceptics, Knoxville, TN) or an Arcus II scanner
(AGFA, Ridgefield, NJ). 
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Two-dimensional gel electrophoresis was done according to von Box-
berg (1988) using the Bio-Rad Mini PROTEAN II 2-D cell. In brief, for
first dimension IEF, each sample contained 3 
 
m
 
l of Lan3-2 antigen from
the original purification (equivalent to antigen from six leech nerve cords)
in 10 mM NH
 
4
 
CO
 
3
 
, 0.02% SDS, pH 7.8, which was mixed with 17 
 
m
 
l of
IEF sample buffer (8.5 M urea, 2% NP-40, 5% 
 
b
 
-mercaptoethanol; 1.6%
Bio-Lyte 5/7 ampholyte, 0.4% Bio-Lyte 3/10 ampholyte 5–8 [Bio Rad Labo-
ratories]). The IEF gels were run at a constant current of 200 
 
m
 
A for 15
min followed by a setting of 500 V constant voltage for 3.5 h. The two-
dimensional electrophoresis was performed with 7.5% SDS-PAGE. The
electroblot transfer and immunodetection of the proteins were as de-
scribed above.
 
Immunoprecipitation.  
 
Immunoprecipitations with Lan3-2 antibody
were performed at 4
 
8
 
C. Dissected 
 
Haemopis
 
 leech nerve cords were ho-
mogenized in extraction buffer (see above) and the homogenate (20 
 
m
 
l)
was incubated with the nonspecific mouse IgG conjugated to protein
G–Sepharose matrix for 2 h. The resulting supernatant was then incu-
bated with purified Lan3-2 antibody conjugated to protein G–Sepharose
matrix (10 
 
m
 
l) for 1 h. After a brief spin for 20 s at 2,000 rpm, the superna-
tant was discarded, and the immunoaffinity matrix was resuspended and
washed sequentially with 400 
 
m
 
l for 5 min of: (
 
a
 
) extraction buffer; (
 
b
 
) 50
mM Tris-HCl, 1 M NaCl, 0.2% NP-40, pH 8.2; (
 
c
 
) 20 mM Tris-HCl, 2 M
NaSCN, 0.1% NP-40, pH 8.2; (
 
d
 
) 20 mM Tris-HCl, 4 M urea, 0.1% NP-40,
pH 7.5; (
 
e
 
) 0.2 M glycine-HCl, 0.1% NP-40, pH 2.5; and (
 
f
 
) extraction
buffer. The final pellet was resuspended in 20 
 
m
 
l of SDS-PAGE sample
buffer and boiled for 5 min before centrifugation and analysis of the su-
pernatant by SDS-PAGE and immunoblotting.
 
Immunohistochemistry
 
Dissected 
 
Hirudo
 
 embryos were fixed overnight at 4
 
8
 
C in 4% paraformal-
dehyde in 0.1 M phosphate buffer, pH 7.4. The embryos were incubated
overnight at room temperature with diluted antibody (Lan3-2, 1:75; Lan4-
2, straight; acetylated tubulin mAb, 1:1,000; 4G5 ascites, 1:1,000; rabbit or
mouse pep6 antiserum, 1:1,000) in PBS containing 1% Triton X-100, 10%
normal goat serum, 0.001% sodium azide; washed in PBS with 0.4% Tri-
ton X-100; and incubated with HRP-conjugated goat anti–mouse or goat
anti–rabbit antibody (1:200 dilution; Bio Rad Laboratories). After wash-
ing in PBS, the HRP-conjugated antibody complex was visualized by reac-
tion in DAB (0.03%) and H
 
2
 
O
 
2
 
 (0.01%) for 10 min. The final prepara-
tions were dehydrated in alcohol, cleared in xylene, and embedded as
whole mounts in Depex mountant (BDH, Poole, UK). Double-labeled
preparations were obtained by a subsequent incubation in the other pri-
mary antibody and by using fluorescently conjugated subtype-specific sec-
ondary antibodies. A rabbit anti–mouse IgG Texas red–conjugated sec-
ondary antibody (Cappel Laboratories, Malvern, PA) was used for Lan3-2,
and a rabbit anti–mouse IgG
 
2B
 
 FITC-conjugated secondary antibody
(Cappel Laboratories) was used for the acetylated tubulin antibody. Fluo-
rescently labeled preparations were mounted in glycerol with 5% 
 
n
 
-propyl
gallate. The labeled preparations were photographed on an Axioskop
(Carl Zeiss, Inc., Thornwood, NY) using Ektachrome 64T or Ektar 100
daylight film (Eastman Kodak Co.). The color positives were digitized us-
ing Adobe Photoshop (Adobe Systems, Inc., Mountain View, CA) and a
Coolscan slide scanner (Nikon Inc., Garden City, NY). In Photoshop the
images were converted to black and white and image processed before be-
ing imported into Freehand (Macromedia) for composition and labeling.
In some cases, digital images were obtained using a high resolution cooled
CCD camera, a PixelBuffer framegrabber, and the NIH-Image software.
 
Lan3-2 Perturbation Experiments
 
1–2 
 
m
 
l of purified Lan3-2 or purified mouse IgG
 
1
 
 (Sigma Chemical Co.)
control antibody from a 0.2 mg/ml stock solution was injected beneath the
germinal plate of E8 
 
Hirudo
 
 embryos. In addition to antibody, the stock
solution contained 10% Ringer solution and 0.2% fast green (Sigma
Chemical Co.), allowing for visual confirmation of pressure-injected anti-
body under the stereo microscope. For the injections the embryos were
immobilized in crevices in Sylgard-coated tissue-culture dishes while anes-
thetized with 8% ethanol in 10% Ringer solutions. After the injection the
embryos were transferred to embryo water without ethanol and allowed
to develop for 24 h at 25
 
8
 
C. At this time the embryos were dissected, fixed,
and processed for antibody labeling. In most experiments the embryos
were labeled or relabeled overnight by incubation in Lan3-2 antibody su-
pernatant, and the labeling was visualized with either HRP- or Texas red–
conjugated anti–mouse IgG secondary antibody. However, in some cases
of Lan3-2–injected embryos, only the Texas red–conjugated secondary an-
tibody was applied. In addition, after examination of Lan3-2–perturbed
fluorescently labeled embryos, some were demounted, reprocessed, and
labeled with acetylated tubulin mAb, and the labeling was visualized with
FITC-conjugated anti–mouse IgG
 
2B
 
 secondary antibody. 31 embryos from
three different cocoons were examined: 15 were injected with purified
Lan3-2 antibody, 12 with IgG
 
1
 
 mouse control antibody, and 4 served as
uninjected controls (1 uninjected control embryo failed to develop and
was not considered in the analysis). In each experiment, sibling embryos
at synchronized developmental stages from the same cocoon were com-
pared at the different experimental conditions. For measuring the area oc-
cupied in the neuropil by the sensory afferents, we used a method similar
to that of Zipser and Cole (1991). In brief, digital images of the ganglionic
afferents were obtained using the NIH-Image software under a 
 
3
 
63 ob-
jective. The area in pixels covered by the neurites and their filopodia was
traced using the outline tool and converted to square microns. To allow
for comparisons between different preparations, the same four ganglia
(g2–g5) were imaged in each specimen.
 
Results
 
Purification of Lan3-2 130-kD Antigen by 
Immunoaffinity Chromatography
 
Both the Lan3-2 and Lan4-2 antibodies were originally made
toward adult 
 
Haemopis
 
 CNS (Zipser and McKay, 1981),
but they label growth cones and developing axon fascicles
of sensory neurons (Fig. 1) in all leech species examined
representing two different orders (Johansen et al., 1992).
The antigens are surface glycoproteins and, on immuno-
blots of adult CNS extract from 
 
Haemopis
 
, Lan3-2 recog-
nizes several protein bands of different molecular weights
including a broad 130-kD band (McKay et al., 1983; Jo-
hansen et al., 1992). In contrast, Lan4-2 recognizes only a
130-kD protein band, and cross-immunoprecipitation ex-
periments with Lan3-2 and Lan4-2 have demonstrated
that the 130-kD antigens of these antibodies are closely
molecularly interrelated (Johansen et al., 1992). The sig-
nificance of the other bands recognized by Lan3-2 is pres-
ently unclear, since immunoblots of embryonic CNS sug-
gest that in E8–E10 embryos, when the Lan3-2–positive
fascicles are being formed, only the 130-kD version of the
antigens is expressed (McGlade-McCulloh et al., 1990).
Thus, these experiments suggest that the 130-kD protein
may be the key molecular form of the Lan3-2 antigens in-
volved in the formation of the axon fascicles, being the
only form expressed when the fascicles are first pioneered.
For these reasons we set out to identify and molecularly
clone the 130-kD protein(s) recognized by the Lan3-2 and
Lan4-2 antibodies.
Since the Lan3-2 antibody recognizes a glycoepitope
(McKay et al., 1983), it was not possible to screen directly
a bacteriophage-based expression vector library using
Lan3-2. Therefore, it was necessary to first purify the anti-
gen, which makes up only 
 
z
 
0.004% of extractable leech
nerve cord protein (Johansen et al., 1992). As a first step
we purified Lan3-2 antibody over a protein G–Sepharose
column from supernatant of Lan3-2 antibody-producing
hybridoma cells grown in serum-free media. The purified
antibody was covalently coupled to protein G–Sepharose
to construct an immunoaffinity column to which extracts
of dissected 
 
Haemopis
 
 leech nerve cords solubilized in Tri-
ton X-100/NP-40 buffer were applied. The solubilized pro-
tein was precleared by incubation with nonspecific mouse
IgG coupled to protein G–Sepharose, and the final Lan3-2 
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Figure 1. Axonal tracts labeled by the mAbs Lan3-2 and Lan4-2 in Hirudo CNS. (A) Lan3-2 labels a glycoepitope expressed by periph-
eral sensory neurons, the axons of which enter the CNS through the median anterior (MA) and dorsal posterior (DP) nerves and segre-
gate into four distinct axonal tracts (arrows). The leech nervous system is bilaterally symmetrical, and anterior is to the left in this and all
the following figures. (B) Lan4-2 labels a different glycoepitope expressed by a small subset of the Lan3-2–positive neurons, the axons of
which segregate into a single axon tract (arrows). Bar, 25 mm.The Journal of Cell Biology, Volume 138, 1997 148
antibody column was washed stringently with 1 M NaCl con-
taining detergent. However, specifically eluting the bound
antigen from the column proved to be difficult as the affin-
ity of the antibody for the antigen was so high that neither
low nor high pH conditions eluted the Lan3-2 antigen. A
variety of other eluates used (4 M MgCl2, 4 M urea, and 3
M NaSCN) also proved to be unsuccessful. Finally, by tak-
ing advantage of the fact that methyl a-d-mannopyrano-
side can block Lan3-2 antibody labeling on immunoblots
(McKay et al., 1983), we found that 0.5 M methyl a-d-
mannopyranoside could be used to compete off the Lan3-2
binding. This method of elution was not very efficient but
proved to be highly specific. After dialysis and concentra-
tion, SDS-PAGE, and blotting onto polyvinylidene difluo-
ride membrane, z10 mg of immunopurified antigen was ob-
tained from 200 nerve cords by this method. Fig. 2 A shows
the purified antigen on a Western blot stained with amido
black from which microsequence was obtained together
with a corresponding immunoblot labeled with Lan3-2 an-
tibody. Only the broad 130-kD band was cut out and ana-
lyzed for the reasons stated above. The purified protein
was trypsin digested in situ, and the resulting peptides were
separated by microbore HPLC and screened by mass spec-
trometry. Seven peaks were selected for gas phase mi-
crosequencing, from which the eight sequences shown in
Fig. 2 A were deduced (one of the peaks contained two
peptide sequences). Searches of the databases showed that
all eight peptides represented novel sequences; however,
pep2, 3, 5, and 7 exhibit sequence homology with the Ig-
like domains of various neural CAMs of the L1 subfamily
(Hortsch, 1996). In addition, pep6 shows homology to
FNIII-like domains of the NCAM/FasII/ApCAM subfam-
ily (Cunningham et al., 1987; Harrelson and Goodman, 1988;
Mayford et al., 1992), whereas pep1, 4, and 8 have no ho-
mology to any known protein sequence in the databases.
The observation that some of the peptide sequences
showed homology to different subfamilies of CAMs raised
the possibility that we had obtained peptide sequences
from more than one protein that comigrate in the broad
130-kD band recognized by Lan3-2. To account for this
possibility, we adopted a cloning strategy where we made
mono- and polyclonal antibodies in mice and rabbits to
synthetic peptides based on the sequence from pep2, 3,
and 6 (Fig. 2 A). As shown in Fig. 2 B, antisera to all three
peptides recognized a broad 130-kD band on immunoblots
of Haemopis nerve cord extracts, indicating that the pep-
tides were indeed derived from the targeted proteins. Fur-
thermore, the peptide antibodies cross-reacted with simi-
larly sized proteins from nerve cord extracts from Hirudo
(data not shown). Consequently, we used these rabbit an-
tisera to the peptides to screen a Hirudo randomly primed
cDNA library.
Molecular Cloning and Characterization of Tractin
and LeechCAM
From z106 clones screened with pep2 antiserum, a single
partial cDNA clone was identified. The predicted amino
acid sequence of this clone contained the exact peptide se-
quence of pep2 (Figs. 3 A and 4), confirming its identity.
Subsequently, the cDNA library was rescreened with radio-
labeled nucleotide probes generated from the 59 and 39
ends of the original cDNA clone. In this way, five addi-
tional independent and overlapping cDNA clones were iso-
lated, which encompassed the entire coding sequence (Fig.
4). The predicted sequence is for a protein containing
1,880 amino acids with several novel features (Figs. 3 A
and 4) that we have named Tractin since it is expressed on
axon tracts. Sequence analysis suggests that the first 25 amino
acids are a cleaved signal peptide (Von Heijne, 1983). An-
other hydrophobic region near the COOH-terminal end is
indicative of a putative transmembrane domain and is fol-
lowed by a short cytoplasmic tail. The extracellular part of
Tractin contains four structural domains (Fig. 4) beginning
with a region of six Ig-like domains. Ig-like domains con-
sist of two b sheets that are stabilized by a characteristic
disulfide bond and can be categorized into different types
(V, C1, C2, or I) depending on key amino acid features
(Harpaz and Chothia, 1994; Vaughn and Bjorkman, 1996).
The Ig-like domains of Tractin are predicted to belong to
Figure 2. Peptide sequences
and new antibodies from pu-
rified Lan3-2 130-kD antigen
in  Haemopis. ( A ) Western
blot of Lan3-2 immunoaffin-
ity-purified antigen from
Haemopis CNS labeled with
amido black (lane 1) com-
pared with an immunoblot of
the same material labeled by
Lan3-2 antibody (lane 2).
The broad 130-kD band was
cut out as indicated on the
figure and microsequenced.
Eight peptide sequences
were deduced as shown to
the right. (B) Western blots
of Haemopis CNS proteins
labeled by rabbit antisera
that were made to synthetic
peptides based on the sequences from pep2, pep3, and pep6 shown in bold in A. All three peptide antisera were specific to the broad
130-kD band. 200 kD is at the top of the blots in A and B, and 25 kD is at the bottom.Huang et al. Differential Glycosylation of Tractin and LeechCAM 149
the I-set. The six Ig-like domains are followed by four
FNIII-like domains (Hynes, 1990). The second FNIII-like
domain contains an RGD tripeptide sequence that is a
characteristic binding sequence for integrins (Hynes, 1992).
In the region after the fourth FNIII-like domain, there is
an acidic block of 64 amino acids of which more than half
of the residues are either aspartate or glutamate. A dot-
plot analysis of the tractin sequence against itself shows
that about a fourth of the protein is made up of a repeat
sequence (Fig. 5 A). A sequence alignment (Fig. 5 B)
shows that this region contains 12 repeats of a 30–amino
acid motif rich in prolines and glycines in which 10 posi-
tions are invariant. The residues of the repeats are most
highly conserved in the first half, whereas the length and
sequence of the repeats are more variable in the second
half. The consensus sequence for the repeats has a proline
at each third residue and is made up of 10 repetitions of
the triplet PG/YG. The 12 repeat segments are interspersed
by short linkers of variable length. There are no known
homologies in the protein databases to either the acidic or
the PG/YG repeat region. The cytoplasmic tail has a stretch
of residues (Fig. 5 C) that conforms to the consensus se-
quence for ankyrin binding domains (Davis and Bennett,
1994; Dubreuil et al., 1996), suggesting that Tractin may
interact with the cytoskeleton. In addition, the extreme
COOH-terminal end of Tractin contains the sequence
SSFV that matches the XS/TXV motif that is predicted to
associate with PDZ domains of the PSD-95/discs-large/
ZO-1 family of membrane skeletal proteins (Doyle et al.,
1996). Interestingly, this XS/TXV PDZ domain binding
motif is also found in several neural cell adhesion mole-
cules such as NrCAM and Drosophila FasII, and in a neu-
roglian isoform (Kornau et al., 1995; Hortsch et al., 1990).
In the extracellular part Tractin has 19 possible N-linked
glycosylation sites.
The predicted molecular mass of Tractin is 200 kD, or
197 kD after cleavage of the signal peptide. This is much
larger than the size of the 130-kD Lan3-2 antigen. However,
the protein contains a putative cleavage site of RKRRSRSK
in the third FNIII-like domain (Fig. 3 A); a similar sequence
motif is also found in FNIII-like domains in CAMs of the
L1 subgroup where in several cases it has been demon-
Figure 3. The predicted protein sequence of Tractin and Leech-
CAM in Hirudo. The cDNAs for Tractin (A) and LeechCAM (B)
encode two novel members of the Ig superfamily. The cysteines
of the Ig-like domains are indicated by arrowheads; potential
N-linked glycosylation sites are indicated by stippled boxes; the
hydrophobic signal sequences are underlined; and the putative
transmembrane domains are double underlined. In addition, the
sequences matching the deduced peptide sequences from the mi-
crosequencing of immunopurified Haemopis Lan3-2 antigen are
shown in bold. Where the sequences are not an exact match, this
difference could be due to a misassignment during microsequenc-
ing and/or species differences. The predicted Tractin protein se-
quence (A) consists of 1,880 residues or 1,855 without the signal
sequence with an estimated molecular mass of 197 kD. It contains
an RGD integrin binding motif (boxed), a putative RKRRSRSK
peptide cleavage site (boxed), and a 60-residue highly acidic do-
main (stippled underline). The predicted LeechCAM sequence
(B) is for a protein of 858 amino acids or 841 without signal se-
quence with an estimated molecular mass of 95 kD. These se-
quence data are available from EMBL/GenBank/DDBJ under
accession numbers U92813 (Tractin) and U92814 (LeechCAM).
Figure 4. Diagrams of the Tractin and LeechCAM proteins. The
protein sequence of Tractin is organized into six Ig-like domains,
four FNIII-like domains, an acidic domain, a PG/YG repeat–con-
taining domain, a transmembrane domain, and an intracellular
domain with an ankyrin binding motif. The locations of the RGD
integrin binding motif in the second FNIII-like domain and the
putative peptide cleavage site in the third FNIII-like domain are
indicated. Above the diagram of Tractin and below the Leech-
CAM protein sequence are partial restriction maps of the cDNAs
relative to the independent, overlapping cDNA library clones
from which the complete sequences were compiled (black lines).
The protein sequence of LeechCAM consists of five Ig-like do-
mains, two FNIII-like domains, a transmembrane domain, and a
short intracellular tail. As indicated on the figure, the Tractin and
LeechCAM sequence each matched four of the eight originally
microsequenced peptides from the Lan3-2 immunopurification.
In addition, the sequences used for Northern blot analysis are in-
dicated as stippled lines below the restriction maps. Three differ-
ent sequences (A, B, and C) were used to probe Tractin Northern
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strated to serve as an actual cleavage site (Burgoon et al.,
1991, 1995; Kayyem et al., 1992; Volkmer et al., 1992). Cleav-
age of Tractin at this site would give rise to a secreted pro-
tein of 97 kD that, with glycosylation taken into account,
would correlate well with the observed size of the Lan3-2
antigen on immunoblots. Northern analysis of leech mRNA
suggests that Tractin may be alternatively spliced into a
major and a minor transcript of 9.3 and 8.5 kb, respectively
(Fig. 6). Both of these transcripts are recognized by Trac-
tin sequence probes from the Ig domain region, the PG/
YG repeat region, as well as the cytoplasmic tail region
(data not shown), and are more than large enough to en-
code for the entire sequence of Tractin. This finding, to-
gether with the fact that neither Lan3-2, pep2, nor pep3
antibodies recognize a full-length 197-kD version of the
protein on immunoblots, suggests that Tractin may be
cotranslationally cleaved into a secreted as well as a 100-kD
transmembrane protein.
Comparison of the eight microsequenced peptides with
the full-length Tractin protein shows that only four of these
peptides (pep2, 3, 5, and 8) are matched by Tractin se-
quence (Figs. 3 A and 4). This suggests that at least one
other protein was copurified with Tractin. We therefore
rescreened the Hirudo cDNA expression library with pep6
antiserum and obtained two independent partial cDNA
clones. Radiolabeled nucleotide probes generated from
the 59 and 39 ends of these cDNA clones were then used to
obtain three additional overlapping cDNAs that encom-
passed the entire coding sequence. The predicted sequence
is for a protein of 858 amino acids with five Ig-like do-
mains, two FNIII-like domains, a putative transmembrane
domain, and a cytoplasmic tail (Figs. 3 B and 4). The first
17 residues define a hydrophobic stretch and are likely to
be a cleaved signal peptide (Von Heijne, 1983). That the
correct protein was cloned was verified by the presence of
the pep6 sequence within the second FNIII-like domain
Figure 5. The PY/GG re-
peat region of Tractin and se-
quence comparison of the
ankyrin binding motif. (A)
Dot plot of the Tractin
amino acid sequence. The se-
quence was analyzed for sim-
ilar sequences within itself by
the computer program
COMPARE with a strin-
gency of 10 and window
length of 8. Points at which
the two sequences are ho-
mologous are indicated by
dots. The plot reveals an ex-
tended region encompassing
z25% of the entire amino
acid sequence with an inter-
nal repeat structure. (B) A
sequence alignment of the region identified in A demonstrates that it is made up of 12 repeats of a 30–amino acid motif rich in prolines
and glycines in which 10 positions are invariant (asterisks). The consensus sequence for the repeats shown at the bottom is made up of
10 repetitions of the amino acid triplet PY/GG. The 12 repeat segments are connected by short linker sequences. Proline, glycine, and
tyrosine residues are highlighted in white letters on a black background. (C) Sequence alignment of the ankyrin binding motif of the in-
tracellular domain with comparable sequences from members of the L1 subfamily of CAMs: neurofascin (S26180), nrcam (P35331), L1
(P11627), ngcam (Q03696), and Drosophila neuroglian (P20241). Conserved residues of these sequences with Tractin are highlighted in
white letters on a black background.
Figure 6. Northern blot analysis of Tractin and LeechCAM mRNA.
20 mg of total Hirudo polyA1 mRNA was fractionated on a 1.2%
agarose formaldehyde denaturing gel, transferred to nitrocellu-
lose, and probed under high stringency conditions using random
primer–labeled Tractin and LeechCAM sequences. For Tractin,
sequences from a 59 end EcoRI fragment coding for the first five
Ig-like domains were used, and for LeechCAM, sequences from a
59 EcoRI fragment coding for the first three Ig-like domains were
used (see Fig. 4). For Tractin, a major band at 9.3 kb and a minor
band at 8.5 kb were detected, whereas a single band of 4.2 kb was
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(Figs. 3 B and 4). That the sequences are not an exact
match could be due to a misassignment during microse-
quencing and/or to species differences. The microsequence
was obtained from Haemopis protein whereas the cDNA
is from Hirudo (the degree of protein sequence identity
between two other proteins, a neurofilament and a volt-
age-gated K-channel, that have been cloned in both
Hirudo and Haemopis is z95%; unpublished results). The
domain organization of the protein is similar to that of
NCAM, FasII, and ApCAM, to which it has sequence ho-
mology in the range of 26–30% based on identical amino
acids, suggesting it is the leech homologue of these pro-
teins. Consequently, we have named the protein Leech-
CAM. The calculated molecular mass of LeechCAM is 97
kD, or 95 kD after cleavage of the signal peptide. It has 10
potential N-linked glycosylation sites in the extracellular
region and is recognized by pep6 antibody as a 130-kD
protein on immunoblots (Fig. 2 B), suggesting that 35 kD
or z27% of its molecular mass is due to glycosylation. On
Northern blots of leech mRNA, it is identified as a single
transcript of 4.3 kb (Fig. 6). In addition to the pep6 se-
quence, the sequence of pep1, 4, and 7 is found within
LeechCAM, thus accounting for all eight of the originally
sequenced peptides.
Differential Glycosylation and Immunocytochemical 
Localization of Tractin and LeechCAM
Immunoaffinity chromatography purification with Lan3-2
antibody yielded two proteins, which raised the question of
whether both Tractin and LeechCAM carry the Lan3-2
epitope or whether one or the other is an interacting pro-
tein without the Lan3-2 epitope that may have been co-
purified. To address this question we immunoprecipitated
leech CNS proteins with purified Lan3-2 antibody co-
valently coupled to a protein G–Sepharose matrix. We
then took advantage of the very high affinity binding of
the Lan3-2 antibody to its antigen by sequentially washing
the precipitate with 1 M NaCl, 4 M MgCl2, 3 M NaSCN,
and 4 M urea. These very stringent washing conditions
would be expected to break most noncovalent protein–
protein associations. The Lan3-2 immunoprecipitate was
then boiled, separated by SDS-PAGE, and immunoblot-
ted. Fig. 7 A shows that a 130-kD band was recognized by
Lan3-2, Tractin, and LeechCAM, as well as by Lan4-2 an-
tibody. This indicated that Tractin and LeechCAM were
most likely copurified because both proteins are glycosy-
lated with the Lan3-2 epitope. In addition, Tractin and
LeechCAM antibody to the protein core only recognized
the 130-kD proteins and not the other molecular mass
bands recognized by Lan3-2 antibody, suggesting that
these are different proteins being glycosylated with the
Lan3-2 epitope in the adult nervous system (Fig. 7 A).
Unfortunately, neither the mAb 4G5 nor any of the new
antisera raised against core protein sequences of either
Tractin or LeechCAM were able to immunoprecipitate ei-
ther of these proteins specifically. Thus, to confirm the
presence of both the Lan3-2 and Lan4-2 epitopes on Trac-
tin and LeechCAM, we separated leech CNS proteins
from the original purification (Fig. 2 A) by two-dimen-
sional gel electrophoresis with IEF in the first dimension
and SDS-PAGE in the second. The separated proteins
were transferred to nitrocellulose and probed separately
with Lan3-2, Lan4-2, mAb 4G5 toward pep2 of Tractin,
and mouse polyclonal antiserum against pep6 of Leech-
CAM. By this procedure we were able to clearly separate
the LeechCAM and Tractin proteins. LeechCAM antise-
rum recognizes a diffuse spot on the gel (Fig. 7 B, arrow-
head), which is not labeled by Tractin antibody. Con-
versely, Tractin recognizes the 130-kD protein in a broad
Figure 7. Tractin and Leech-
CAM are separate proteins
that are both glycosylated
with the Lan3-2 and Lan4-2
epitopes. (A) Immunoblots
of Lan3-2–immunoprecipi-
tated  Haemopis nerve cord
proteins. The immunopre-
cipitate was sequentially
washed with 1 M NaCl, 4 M
MgCl2, 3 M NaSCN, and 4 M
urea before separation by
10% SDS-PAGE. A broad
130-kD band (arrow) was
recognized by both Lan3-2
and Lan4-2 and by Tractin
(pep2) and LeechCAM
(pep6) antisera (200 kD is at
the top and 25 kD is at the
bottom of the blot). (B) Im-
munoblots of immunoaffin-
ity-purified Lan3-2 antigen from Haemopis nerve cords separated by two-dimensional-gel electrophoresis. The purified nerve cord pro-
teins were subjected to IEF in the first dimension (range: pH 4.5–8.5) and 7.5% SDS-PAGE in the second (200 kD is at the top and 25
kD is at the bottom of the blot). LeechCAM antiserum (B3) recognizes an oblong diffuse 130-kD spot (the arrow indicates the location
of this position in all four panels) that is not labeled by the Tractin mAb 4G5 (B4). In contrast, the Tractin mAb 4G5 labels 130-kD pro-
tein in a broad range of more basic pHs (B4) that are not labeled by the LeechCAM antiserum (B3). Both Lan3-2 and Lan4-2 label pro-
teins in a pattern matching the combined pattern of Tractin and LeechCAM antibody (B1 and B2).The Journal of Cell Biology, Volume 138, 1997 152
range of pH, which is not labeled by LeechCAM antibody.
However, the combined pattern of LeechCAM and Trac-
tin antibody labeling matches that of both Lan3-2 and
Lan4-2. This suggests that Tractin and LeechCAM are
separate proteins that both can be glycosylated with the
Lan3-2 and Lan4-2 epitopes. However, it should be noted
that we only clearly resolved the proteins in the 130-kD
region; the other and less efficiently purified proteins rec-
ognized by Lan3-2 (Fig. 2 A, lane 1) were in most cases be-
low the threshold of detection in this analysis. The predicted
IEF points for LeechCAM and the secreted Tractin core
proteins are pH 4.7 and 5.5, respectively. This is consistent
with their relative position on the immunoblots although
their observed values are shifted toward more basic pHs.
This observation and their distribution over a wide range
of pH, instead of being focused into tight spots, probably
reflect heterogeneous glycosylation of the core proteins as
has been previously described for other glycosylated CAMs
(Rathjen et al., 1987a,b; Wolff et al., 1988). Furthermore,
since all eight microsequenced peptides were found in the
sequence of Tractin and LeechCAM, they may represent
the only two 130-kD proteins carrying these glycoepitopes,
although the existence of one or more additional proteins
cannot be rigorously excluded.
We examined the developmental expression of Tractin
and LeechCAM by labeling E10 Hirudo embryos with
Tractin (mAb 4G5)– and LeechCAM (mouse antiserum)–
specific antibodies (Fig. 8) (similar results were obtained
with the rabbit antisera; data not shown). We found that
Tractin was detected by the mAb 4G5 on the soma and ax-
ons of all neurons of both the central and peripheral ner-
vous system (Fig. 8 A). We suspect this also to be the case
for LeechCAM; however, the immunocytochemical label-
ing with the mouse polyclonal antiserum was not as robust
as for the Tractin mAb, allowing us only to identify posi-
tively labeling of central neurons, sensilla, and a few of the
other peripheral neurons such as the nephridial nerve cell
(Fig. 8 B). At this developmental stage, Lan3-2 labels all
peripheral sensillar neurons and their projections (Fig. 8 C),
whereas Lan4-2 labels only a small subset of these that fas-
ciculate into a single tract (Fig. 8 D). These results indicate
that Tractin and LeechCAM are widely expressed pro-
teins in the leech nervous system; however, they are differ-
entially glycosylated to carry the Lan3-2 glycoepitope in
the sensillar neurons only and, in a distinct subset of these
sensillar neurons, they are additionally modified to also
carry the Lan4-2 glycoepitope.
In Vivo Perturbation of Neurite Extension and Fascicle 
Formation of Sensillar Neurons by Lan3-2 Antibody
To test whether the differential glycosylation of Tractin
and LeechCAM functions in neuritogenesis and/or fascicle
formation of the sensillar neurons in vivo, we injected puri-
fied Lan3-2 antibody (0.2–0.5 mg) beneath the germinal
plate cavity of sibling E8 embryos (Fig. 9). Assuming a vol-
ume of z20 ml for an E9 embryo germinal plate, this would
result in an effective antibody concentration of 10–25 mg/ml,
which is comparable to the highest concentrations used in
the in vitro perturbation studies by Zipser et al. (1989)
and Song and Zipser (1995a). Embryos, either not injected
or injected with a nonspecific purified mouse IgG1 fraction
Figure 8. Tractin and LeechCAM are widely expressed proteins that are differentially glycosylated with the Lan3-2 and Lan4-2 epitopes
in distinct subpopulations of peripheral sensory neurons. (A–D) Hemisegments of Hirudo embryos at approximately the same develop-
mental stage (E10–11) labeled by Tractin (mAb 4G5 to pep2), LeechCAM (mouse antiserum to pep6), Lan3-2, and Lan4-2 antibody.
Tractin antibody (A) labels the soma and projections of all neurons in both the central (G) and peripheral nervous system. S6 and S7 in-
dicate the location of the dorsal sensilla, whereas some of the somata of nonsensillar peripheral neurons are indicated by arrows. Leech-
CAM antibody (B) labels central (G) and sensillar neurons (S6 and S7) and their projections in the four peripheral nerves (AA, MA,
DP, and PP), in addition to unidentified cells in tissue forming the nephridiopore (N). Lan3-2 (C) recognizes a glycoepitope expressed
on the soma and axons of all sensillar neurons. Their axons project into the CNS (G) through the MA and DP nerves where they segre-
gate into four distinct fascicles. Lan4-2 (D) recognizes a different glycoepitope expressed by a subset of the Lan3-2–positive sensillar
neurons, the axons of which segregate into a single tract in the CNS (G). Bars: (A and B) 75 mm; (C and D) 100 mm.Huang et al. Differential Glycosylation of Tractin and LeechCAM 153
in equal amounts to that of the Lan3-2 antibody, served as
controls. After injection the intact embryos were incu-
bated for 24 h in embryo water before dissection and fixa-
tion. In some experiments with Lan3-2–injected embryos,
the fixed embryos were relabeled with Lan3-2 antibody
and Texas red–conjugated second antibody, while in oth-
ers only fluorescently conjugated secondary antibody was
applied. The results from both methods were indistin-
guishable, demonstrating that the injected Lan3-2 anti-
body is stable and has full access to its epitope. At the time
of injection at E8, the growth cones of the sensillar neu-
rons in anterior segments have just reached the ganglionic
neuropil before their bifurcation into fascicles in the CNS
(Fig. 9 A). During normal development in the ensuing 24 h,
more and more sensillar neurons extend neurites into the
CNS (Jellies et al., 1994). These neurites have numerous
filopodia that branch extensively in the neuropil as the
projections segregate into distinct fascicles (Fig. 9 B). In
contrast, in the presence of Lan3-2 antibody the extension
of neurites and filopodia at the bifurcation point is se-
verely impaired, as shown in Fig. 9 C, where the sensillar
projections clearly are stunted, although indications of fas-
cicles are discernible. Of the 15 Lan3-2–injected embryos,
this phenotype was observed in four embryos, whereas six
showed intermediate levels of perturbation, and five em-
bryos showed no discernible difference from controls. Since
none of the 12 embryos injected with IgG1 control anti-
body were distinguishable from uninjected controls, the
perturbation phenotype seen in a majority of the embryos
is likely to be a consequence of the presence of Lan3-2 an-
tibody (application of a x2-test shows that the phenotype
distribution of Lan3-2–injected embryos is significantly
different from that of the control distribution [P , 0.01]).
As an estimate of the degree of inhibition of neurite exten-
sion and branching, we measured the average area occu-
pied by the sensory afferents in the neuropil of four gan-
glia in each of the four embryos most clearly perturbed by
Lan3-2. The average area in these embryos was 577 6 188
mm2 (n 5 32, 6 SD) compared with 1,402 6 240 mm2 (n 5
16, 6 SD) in ganglia from two unperturbed embryos, cor-
responding to an z60% reduction in the average area oc-
cupied by neurites and filopodia. Although the extension
of neurites in the ganglionic neuropil is clearly inhibited by
Lan3-2 antibody, sensillar neurons do appear to differenti-
ate in the periphery under these conditions and remain
fasciculated in the peripheral nerves. Consequently, the
effect of Lan3-2 antibody perturbation of sensillar neurons
may be mainly exerted within the CNS. That rudimentary
fascicles do form during Lan3-2 antibody incubation may
be due to the fact that we have not obtained complete in-
hibition of the function of the Lan3-2 epitope or that some
axons are able to rely on other cues that can partly com-
pensate for the blockage of the Lan3-2 epitope. To verify
that the antibody perturbation was a specific effect on sen-
Figure 9. In vivo perturbation by Lan3-2 antibody of neurite ex-
tension and fascicle formation of sensillar neurons from three
segments. (A) Anterior ganglia labeled by Lan3-2 antibody,
showing the degree of development at the time Lan3-2 antibody
or control mouse IgG1 antibody were injected into sibling em-
bryos at E8. The location of the primordial middle ganglion is in-
dicated by the G, and the arrow points to the choice point for seg-
regation into fascicles of the growth cones of S3 sensillar neurons
that have just entered the ganglionic neuropil. At this stage only
the S3 sensillum has differentiated. (B) Uninjected control em-
bryo from the same cocoon as the embryo in A was dissected,
fixed 24 h later at E9, and labeled with Lan3-2 antibody. The con-
trol embryo shows the extensive elaboration of growth cones and
filopodia at the choice point for segregation of axons into differ-
ent fascicles (arrow). Several fascicles are forming (small arrows)
in both the anterior and posterior direction. The most ventral
sensillum (S1) has differentiated at this stage and extends axons
to the CNS. (C) Sibling embryo of that shown in B injected with
0.5 mg of purified Lan3-2 antibody at E8. As in B, the embryo was
dissected and fixed 24 h later at E9, and the Lan3-2 labeling was
visualized with Texas red–conjugated second antibody. The ax-
ons of the sensilla in the MA nerve are still fasciculated; however,
at the choice point (arrow) in the ganglia (G), the extension of
growth cones and filopodia is greatly reduced and fascicle forma-
tion is truncated. Bar, 40 mm.The Journal of Cell Biology, Volume 138, 1997 154
sillar neurons expressing the Lan3-2 glycoepitope on their
surface and not a general effect on neurons in the CNS, we
relabeled Lan3-2–perturbed embryos with an antibody to
acetylated tubulin that labels central neurons but not sen-
sillar neurons (Jellies et al., 1996) and visualized them with
FITC-conjugated second antibody. As shown in Fig. 10,
the development of central neurons, which also express
Tractin and LeechCAM but without the Lan3-2 glyco-
epitope, appears completely normal in embryos injected
with Lan3-2 antibody. The projections of the central neu-
rons in both the neuropil and in the peripheral nerves (Fig.
10 B) are orderly and indistinguishable from uninjected
controls (Fig. 10 A). Thus, these experiments suggest that
antibody perturbation of the Lan3-2 glycoepitope on sen-
sillar neurons can selectively regulate extension of neu-
rites and filopodia of these neurons at the choice point for
bifurcation and fascicle selection in the CNS neuropil, which
in many cases leads to abnormal and truncated fascicle for-
mation.
Discussion
In this study we have identified and molecularly cloned
the coding sequences for two proteins, LeechCAM and
Tractin, which are differentially glycosylated with the Lan3-2
and Lan4-2 glycoepitopes in peripheral sensory neurons in
leech. Whereas LeechCAM appears to be a leech homo-
logue of NCAM, FasII, and ApCAM, the organization of
Tractin has several unique features. The possession of six
Ig-like domains plus four FNIII-like domains places Trac-
tin in the Ig superfamily. However, no other Ig superfam-
ily member contains sequences similar to the acidic region
or the PG/YG repeats of Tractin, suggesting that Tractin
may define a novel subgroup of these molecules. The orga-
nization of Tractin into six Ig-like and four FNIII-like do-
mains in the extracellular part is similar to that of the
TAG-1/Axonin-1/F3/F11 subgroup of CAMs (Brümmen-
dorf and Rathjen, 1993); however, on the sequence level
this region of Tractin is most homologous (33%) to Dro-
sophila neuroglian (Bieber et al., 1989) and other members
of the L1 subgroup. Other features shared with the L1
group of CAMs (Hortsch, 1996) are the presence of an
ankyrin binding motif in the cytoplasmic tail and of a puta-
tive protease cleavage site in the third FNIII-like domain.
That Tractin is cleaved at this site is supported by the find-
ing that antibodies to NH2-terminal sequence of Tractin
do not recognize a full-length version of the protein on im-
munoblots but only a 130-kD glycosylated fragment. Fur-
thermore, previous studies using phase separation with
Triton X-114 of the Lan3-2 antigens have shown that a
major proportion of the 130-kD proteins partition as
loosely associated peripheral membrane proteins (Bajt et
al., 1990). The nature of such a peripheral attachment is
not known; however, Tractin has an RGD integrin binding
motif in the second FNIII-like domain just upstream of the
putative cleavage site that could potentially anchor it to
the cell surface via association with integrins. A similar
mechanism  has been proposed for the secreted TAG-1/ax-
onin-1 isoforms (Felsenfeld et al., 1994) that are without
glycosylphosphatidylinositol linkers but that also have an
RGD motif in their second FNIII-like domains (Ruegg et
al., 1989a,b; Furley et al., 1990; Karagogeos et al., 1991).
Cleavage at the third FNIII-like domain of Tractin would
in addition yield a 100-kD transmembrane protein, the ex-
tracellular domain of which would be made up largely of
the region of the 12 PG/YG repeats. The sequence of this
region, although considerably more structured, is reminis-
cent of that of collagen, which also has sequence rich in
glycines and prolines and contains the iterated motif GX1X2
where X1 and X2 often are prolines (Miller and Gay, 1987).
Collagen is a major constituent of extracellular matrix and
basal lamina and can form fibrils made up of triple a heli-
ces. The PG/YG repeats alternatively can be considered to
be composed of the triplet GPG/Y, which would conform
with the collagen motif’s requirement of a glycine at every
third residue that facilitates a helix formation. Thus, while
the designation of the repeat as PG/YG is most consistent
with the overall sequence alignment, it is conceivable that
the sequence may structurally have some of the same func-
tional properties as collagen. The linker regions between
the repeats may allow the sequence to fold back upon it-
self and form an intertwined a domain structure (Branden
and Tooze, 1991) or, alternatively, the repeats may inter-
act with other molecules forming the basal lamina. Fur-
thermore, if the prolines were hydroxylated as in collagen,
the PG/YG repeat region potentially could be glycosy-
lated. Thus, this novel domain may constitute membrane-
Figure 10. Central neurons and their projections develop nor-
mally in Lan3-2–injected embryos. (A) Hemisegment of an E9
control embryo labeled with an antibody to acetylated tubulin
that shows the ganglionic nerve tracts and peripheral projections
of central neurons. The figure is a Nomarski image of antibody la-
beling visualized with HRP-conjugated secondary antibody. (B)
Hemisegment of an E9 embryo labeled with acetylated tubulin
antibody that was injected with 0.5 mg of Lan3-2 antibody as in
Fig. 9 C. The organization and extent of central neuron projec-
tions is indistinguishable from that of uninjected controls (A).
The figure is a fluorescence image of antibody labeling visualized
with FITC-conjugated second antibody. G, location of the gan-
glion; AA, MA, DP, and PP; position of the four peripheral
nerves. Bar, 100 mm.Huang et al. Differential Glycosylation of Tractin and LeechCAM 155
attached sequence that has properties similar to that of ex-
tracellular matrix molecules and that may be linked to the
cytoskeleton through interactions with ankyrin. Future
structural and functional analysis should provide insight
into whether this domain participates in organizing extra-
cellular matrix around the neurons and axons, and
whether it serves as a substrate for axon outgrowth and
guidance.
We show by using antibodies specific to the core protein
sequences of Tractin and LeechCAM that these proteins
are widely expressed by both central and peripheral neu-
rons in leech embryos. Furthermore, immunocytochemical
labeling with the Lan3-2 antibody demonstrated that Trac-
tin and LeechCAM are differentially glycosylated with the
Lan3-2 epitope only in sensillar and extrasensillar periph-
eral sensory neurons (see also Jellies et al., 1995), and that
in a small subset of these neurons both proteins are addi-
tionally glycosylated with the Lan4-2 epitope. This implies
that specific glycosyltransferases are selectively expressed
in subpopulations of these neurons and that different
polypeptides can serve as substrates for the modifications.
Interestingly, in addition to the Lan4-2 epitope, the Lan2-3,
Laz2-369, and Laz7-79 glycoepitopes also have been shown
to be present on 130-kD proteins and expressed by sepa-
rate subsets of peripheral sensory neurons (Peinado et al.,
1987; Bajt et al., 1990; Zipser et al., 1994). The identity of
the neurons expressing the different epitopes is not known,
but it has been proposed that neurons sharing a common
sensory modality, such as various types of chemorecep-
tors, mechanoreceptors, and photoreceptors that are
mixed within the sensilla, may express specific carbohy-
drate markers that correlate with their axonal outgrowth
and segregation into specific pathways (Zipser et al., 1994).
Direct evidence that the different oligosaccharide epitopes
can regulate neuronal outgrowth and fascicle formation of
distinct neuron subpopulations has been provided by anti-
body perturbation studies. In this report we show that pu-
rified Lan3-2 antibody injected into the germinal plate of
the living intact embryo inhibits the extension of neurites
and filopodia at the choice points where the sensillar ax-
ons segregate into separate fascicles. These results are sim-
ilar to and confirm those obtained in vitro with incubation
of dissected cultured germinal plates with Fab fragments
of Lan3-2 antibody, which also leads to an impairment of
neurite extension and a reduction in the number of fasci-
cles (Zipser et al., 1989; Song and Zipser, 1995a). Evidence
that this perturbation is specific to the blockage of the car-
bohydrate epitope is provided by experiments showing
that cleaving of carbohydrate moieties with the glycosi-
dase N-glycanase or incubation with mannose coupled to
albumin has the same effect as that of antibody perturba-
tion (Zipser and Cole, 1991). In contrast with the inhibi-
tion of neurite extension by Lan3-2 antibody, in vitro incu-
bation with Fab fragments of the Laz2-369 and Laz7-79
antibodies has an outgrowth-promoting effect on the neu-
rites and filopodia that is specific to the subpopulation of
neurons expressing each of these epitopes (Song and Zip-
ser, 1995b). The proteins carrying the Laz2-369 and Laz7-
79 epitopes are furthermore immunoprecipitated by Lan3-2
antibody (Bajt et al., 1990), suggesting that they may rep-
resent additional modifications to either or both of the Trac-
tin and LeechCAM proteins. Thus, Tractin and LeechCAM
represent protein cores that are differentially glycosylated
in distinct subset of neurons where the specific oligosac-
charide structures may functionally assist in regulating the
outgrowth and patterning of their axonal projections.
Based on the Lan3-2 perturbation experiments in vitro,
it has been proposed that the Lan3-2 glycoepitope is in-
volved in regulating the defasciculation of sensillar neu-
rons at the choice points where they segregate into different
fascicles in the CNS (Zipser et al., 1989). In other systems,
modulation of the polysialic acid content of NCAM in chick
has been implicated as a key regulator of a general form of
axonal defasciculation (Rutishauser and Landmesser, 1996).
However, in leech embryos we found no evidence based
on immunocytochemical labeling that the expression of
the Lan3-2 epitope is dynamically regulated along the ax-
ons, indicating a different functional mechanism. Genetic
experiments in Drosophila with up- and down-regulation
of the CAM FasII, to which LeechCAM is a likely homo-
logue, show that in loss of function mutants the axons that
normally fasciculate together fail to do so, whereas in gain
of function phenotypes normally separate pathways are
joined together and become fused (Grenningloh et al.,
1991; Lin et al., 1994). However, as with the Lan3-2 epi-
tope on Tractin and LeechCAM, the level of expression of
FasII appears uniform along the axons and fascicles, sug-
gesting that modulation of FasII function by interactions
with other molecules is required at the choice points (Fam-
brough and Goodman, 1996). A gene with such a function
that has been recently identified is beaten path, a locus that
genetically interacts with FasII (Fambrough and Good-
man, 1996). beaten path codes for a secreted protein that
by mutational analysis can be shown to regulate the selec-
tive defasciculation at specific choice points of motoneu-
rons. In a similar manner, local interactions involving the
Lan3-2 epitope may be regulating defasciculation of sen-
sillar neurons and facilitating the segregation of their ax-
ons into specific tracts. Alternatively, the Lan3-2 gly-
coepitope may be involved in promoting axonal outgrowth
and neurite extension, the inhibition of which could also
account for the observed perturbation phenotype. There
are many examples of CAMs stimulating axonal growth
(Doherty and Walsh, 1994), and it has been demonstrated
that chromophore-assisted laser inactivation of FasII in
grasshopper prevents the initiation of Ti1 peripheral neu-
ron axonal outgrowth but has no effect on axon fascicula-
tion (Diamond et al., 1993). Furthermore, oligo-manno-
sidic carbohydrates expressed on L1 have been shown to
determine its interaction with NCAM and to modulate
neurite outgrowth (Horstkorte et al., 1993).
In summary, increasing evidence indicates that interac-
tions between surface oligosaccharides and carbohydrate
binding proteins mediate many important cellular pro-
cesses in nonneuronal cells (Springer, 1994; Lasky, 1995);
however, progress in studying such interactions within the
nervous system has been slow partly due to the lack of
probes (Jessell et al., 1990). In leech sensillar neurons, an-
tibodies have identified at least five different glycoepi-
topes that are expressed by distinct populations of these
neurons. Functional studies indicate that these epitopes
may regulate different aspects of axonal outgrowth as well
as the patterning of projections that are specific to the
neuron subpopulations expressing the respective carbohy-The Journal of Cell Biology, Volume 138, 1997 156
drate structures. The identification and cloning of two of
the proteins being differentially glycosylated in this way
promises to facilitate the further analysis of how the differ-
ent physical and biochemical properties of specific carbo-
hydrates may lead to functional diversity and specificity of
widely expressed neural proteins.
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